**Core Concept**
Spironolactone is a potassium-sparing diuretic that acts by antagonizing the effects of aldosterone at the mineralocorticoid receptor, leading to increased sodium excretion and potassium retention. The combination of spironolactone with other drugs that also increase potassium levels can lead to hyperkalemia, a potentially life-threatening condition.

**Why the Correct Answer is Right**
The combination of spironolactone with ACE inhibitors is contraindicated because both drugs increase potassium levels. ACE inhibitors work by inhibiting the conversion of angiotensin I to angiotensin II, leading to vasodilation and decreased aldosterone levels, which in turn increases potassium levels. The concurrent use of spironolactone with ACE inhibitors can lead to excessive potassium retention, resulting in hyperkalemia.

**Why Each Wrong Option is Incorrect**
**Option A:** Chlorothiazide is a thiazide diuretic that acts by inhibiting sodium and chloride reabsorption in the distal convoluted tubule, leading to increased potassium excretion. It is not contraindicated with spironolactone.

**Option B:** Beta blockers do not directly affect potassium levels and are not contraindicated with spironolactone.

**Option D:** Amlodipine is a calcium channel blocker that acts by inhibiting the influx of calcium ions into smooth muscle cells, leading to vasodilation. It does not increase potassium levels and is not contraindicated with spironolactone.

**Clinical Pearl / High-Yield Fact**
It is essential to monitor potassium levels closely when initiating or adjusting the dose of spironolactone, especially in patients taking other potassium-sparing medications or ACE inhibitors. Regular electrocardiogram (ECG) monitoring and potassium level checks can help prevent hyperkalemia.

✓ Correct Answer: C. ACE inhibitors